This study was designed to provide early access to and evaluate the safety of TPV/r in PI-experienced patients with HIV-1 infection.
Study Type
EXPANDED_ACCESS
500 mg twice daily
200 mg twice daily
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
1182.70.127 Health Services Center, Inc.
Anniston, Alabama, United States
1182.70.006 Spectrum Medical Group
Phoenix, Arizona, United States
1182.70.016 Health for Life Clinic
Little Rock, Arkansas, United States
1182.70.065
Anaheim, California, United States
1182.70.246
Baldwin Park, California, United States
1182.70.043
Fountain Valley, California, United States
1182.70.092
Fresno, California, United States
1182.70.057
Glendale, California, United States
1182.70.064
Harbor City, California, United States
1182.70.079
Long Beach, California, United States
...and 105 more locations